Vasculitic neuropathy — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Disease-specific immunotherapy or supportive respiratory monitoring
Disease-specific immunotherapy or supportive respiratory monitoring is the best answer because the vignette describes Vasculitic neuropathy: painful asymmetric axonal neuropathy indicates vasculitic mononeuritis multiplex. Empirical intravenous ceftriaxone after blood cultures is plausible in a neighbouring presentation, but the chronology, examination or investigation pattern does not match the key discriminator here. High-dose intravenous methylprednisolone after excluding infection and Intravenous immunoglobulin with respiratory monitoring are less appropriate because they would require different localisation, timing or test findings; Multidisciplinary rehabilitation with goal-setting would fit a different syndrome. Clinical pearl: CIDP is usually symmetric demyelinating with proximal and distal weakness.
Reference: NICE NG42; ABN myasthenia gravis guidance; EAN/PNS GBS-CIDP guidance